Related Experiment Videos
Lignocaine: a new technique for intravenous administration
British Heart Journal
|September 1, 1977
Summary
A new intravenous lignocaine infusion method prevents subtherapeutic drug levels, reducing the risk of ventricular ectopy. This optimized lignocaine administration ensures consistent therapeutic drug levels, enhancing patient safety and treatment efficacy.
Area of Science:
- Pharmacology
- Cardiology
- Clinical Pharmacy
Background:
- Current intravenous lignocaine administration can lead to a therapeutic gap.
- This gap occurs between the initial bolus peak and continuous infusion steady state.
- The subtherapeutic interval increases the risk of ventricular ectopy.
Purpose of the Study:
- To introduce and evaluate a novel intravenous lignocaine infusion technique.
- To eliminate the subtherapeutic interval in lignocaine plasma levels.
- To assess the safety and efficacy of the new regimen.
Main Methods:
- Seven patients without congestive heart failure or liver disease were studied.
- Lignocaine was infused at a weight-adjusted rate of 25 mg/min.
- Plasma lignocaine levels were monitored to assess therapeutic intervals.
Main Results:
- The novel infusion technique successfully eliminated the subtherapeutic interval.
- No clinical toxicity was observed in the studied patients.
- Consistent therapeutic plasma lignocaine levels were maintained.
Conclusions:
- The new lignocaine infusion method offers significant clinical advantages.
- This technique is beneficial for patients requiring intravenous lignocaine therapy.
- It provides a safer and more effective method for lignocaine administration.